Latest Market News

Immutep Limited has won FDA Orphan Drug Designation for its immunotherapy eftilagimod alfa in treating soft tissue sarcoma, opening regulatory incentives and potential market exclusivity. This follows encouraging Phase II data despite recent Phase III trial setbacks.

Mesoblast has acquired exclusive rights to a patented chimeric antigen receptor platform designed to enhance the targeting and potency of its mesenchymal stromal cell therapies, aiming to expand treatment options for inflammatory and autoimmune diseases.

Larvotto Resources is progressing the Hillgrove Antimony-Gold Project on time and budget, aiming for mid-2026 production amid rising strategic demand for antimony. The project benefits from grid power, ongoing drilling success, and government support for critical minerals.

WhiteHawk Limited has raised A$1.5 million through a share placement to fund integration and growth of its newly acquired Quixxi Clarity AI platform, marking a strategic push into the AI governance market.

Magnum Mining names Antonio Vitor Junior as Managing Director to spearhead major drilling campaigns at its Azimuth and Parker projects, aiming to convert promising early rare earth results into a formal resource.

Xenitra Limited has acquired Hong Kong Fukang Trading Co., including key pharmaceutical licenses and ecommerce assets, to fully operationalise its OTC medicine business in Hong Kong and China.

Strategic Energy Resources has locked in a binding joint venture with Sumitomo Metal Mining Oceania to explore its Bulimba Gold Project in northeast Queensland, with Sumitomo able to earn up to 90% through staged commitments over five years.

Shine Justice reshuffles its top management as Simon Morrison steps down from Managing Director to Executive Director to spearhead international growth, particularly in its burgeoning mass torts program, while Carolyn Barker AM maintains overall CEO leadership.

Orthocell has secured approval for its Remplir™ nerve repair device to be used across 221 U.S. military and veterans hospitals, marking a major step in its U.S. commercial expansion. The approval follows clinical validation in conflict zones, positioning Orthocell to deepen penetration into defence healthcare.

Duratec's joint venture with Ertech has clinched a $281 million contract to upgrade submarine infrastructure at HMAS Stirling, marking a major step in Australia's AUKUS defence preparations.

Cuscal Limited has successfully raised A$30 million through a fully underwritten institutional placement to fund its acquisition of Paymark. The company also launched a Share Purchase Plan targeting an additional A$3 million from eligible shareholders.

Sun Silver has engaged global engineering firm Ausenco to lead critical concept and scoping studies for its Maverick Silver Project in Nevada, aiming to underpin a maiden Scoping Study by late 2026. The move leverages Ausenco’s North American precious metals expertise and comes as silver prices hover near US$77 an ounce, bolstering project economics.